Outside Audits. Covered Entity and Pharmacy understand that they are subject to audits by third parties (e.g., the Department and participating manufacturers) of records that directly pertain to the Covered Entity’s compliance with the drug resale or transfer prohibition and the prohibition against duplicate discounts under this Agreement. Pharmacy warrants to Covered Entity that all pertinent reimbursement accounts and dispensing records maintained by Pharmacy are accessible separately from Pharmacy’s own operations and will be made available to Covered Entity and its external auditors contracted by the Covered Entity, HRSA, or the manufacturer in the case of an audit. Such auditable records shall be maintained for a period of time that complies with all applicable federal, state, and local requirements. In the event Pharmacy is subject to any HRSA or any other federal, state, or local government or governmental agency audit or inspection, Pharmacy shall immediately notify Covered Entity and provide Covered Entity with an opportunity to participate in such audit or inspection. Access to Agreement. Upon written request to the Covered Entity, a copy of this Agreement will be provided to OPA, and to others as required to maintain compliance with the 340B Program.
Appears in 2 contracts
Sources: 340b Contract Pharmacy Services Agreement, 340b Contract Pharmacy Services Agreement